Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Apr 17;9(1):1752563. doi: 10.1080/2162402X.2020.1752563

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 The Author(s). Published with license by Taylor & Francis Group, LLC.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 4. — Subgroup analysis to estimate the survival benefits from sequential CIK cell immunotherapy according to the duration of chemotherapy. (a) Sequential CIK cell immunotherapy significantly prolonged the disease-free survival (DFS) and overall survival (OS) of patients receiving less than 20 weeks of chemotherapy. (b) Sequential CIK cell immunotherapy slightly prolonged the DFS and OS of patients receiving more than 20 weeks of chemotherapy.